Status:
RECRUITING
NeoSCB App for Screening Jaundice in Newborns
Lead Sponsor:
University College, London
Collaborating Sponsors:
University College London Hospitals
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
Up to 28 years
Brief Summary
About 60% of babies born after 36 weeks of pregnancy have jaundice during the first two weeks of life. Due to the accumulation of bilirubin in the bloodstream, jaundiced babies appear yellow, which al...
Eligibility Criteria
Inclusion
- Term newborn babies with and without jaundice (postnatal age 0 day to 28 days)
Exclusion
- Newborn babies who are clinically unwell and require urgent medical attention, and babies who have received phototherapy recently
Key Trial Info
Start Date :
September 23 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
405 Patients enrolled
Trial Details
Trial ID
NCT06963450
Start Date
September 23 2025
End Date
March 31 2027
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL Hospitals
London, United Kingdom, NW1 2BU